BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29942980)

  • 1. Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.
    Zhang T; Xu L; Tang Y; Cui H; Tang X; Wei Y; Wang Y; Hu Q; Qian Z; Liu X; Li C; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):871-877. PubMed ID: 29942980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.
    Zhang T; Xu L; Tang Y; Cui H; Wei Y; Wang J; Tang X; Li C; Wang J
    Psychol Med; 2018 Jun; 48(8):1274-1281. PubMed ID: 29173206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Untreated Prodromal Psychosis and Cognitive Impairments.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Liu H; Wang Z; Chen T; Li C; Wang J
    JAMA Netw Open; 2024 Jan; 7(1):e2353426. PubMed ID: 38277145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis.
    Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Wang Z; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2023 Nov; 329():115522. PubMed ID: 37812943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Duration of untreated psychosis: A state-of-the-art review and critical analysis].
    Souaiby L; Gaillard R; Krebs MO
    Encephale; 2016 Aug; 42(4):361-6. PubMed ID: 27161262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
    Simonsen C; Faerden A; Romm KL; Berg AO; Bjella T; Sundet K; Ueland T; Andreassen O; Melle I
    Psychiatry Res; 2017 Aug; 254():118-125. PubMed ID: 28460281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up.
    Brandizzi M; Valmaggia L; Byrne M; Jones C; Iwegbu N; Badger S; McGuire P; Fusar-Poli P
    J Psychiatr Res; 2015 Jun; 65():115-23. PubMed ID: 25837413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
    Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
    J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to the duration of untreated prodromal positive symptoms in individuals at ultra-high risk for psychosis.
    Chon MW; Lee TY; Kim SN; Huh MJ; Park HY; Lee CR; Shin NY; Kwon JS
    Schizophr Res; 2015 Mar; 162(1-3):64-6. PubMed ID: 25636994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of untreated psychosis predicts treatment outcome in an early psychosis program.
    Black K; Peters L; Rui Q; Milliken H; Whitehorn D; Kopala LC
    Schizophr Res; 2001 Mar; 47(2-3):215-22. PubMed ID: 11278138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.
    Salokangas RK; Heinimaa M; From T; Löyttyniemi E; Ilonen T; Luutonen S; Hietala J; Svirskis T; von Reventlow HG; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Ruhrmann S; Klosterkötter J;
    Eur Psychiatry; 2014 Aug; 29(6):371-80. PubMed ID: 24315804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of attenuated psychotic symptoms in help-seeking youth.
    Hazan H; Spelman T; Amminger GP; Hickie I; McGorry PD; Phillips LJ; Purcell R; Wood SJ; Yung AR; Nelson B
    Schizophr Res; 2020 Jan; 215():277-283. PubMed ID: 31615738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Brucato G; Masucci MD; Arndt LY; Ben-David S; Colibazzi T; Corcoran CM; Crumbley AH; Crump FM; Gill KE; Kimhy D; Lister A; Schobel SA; Yang LH; Lieberman JA; Girgis RR
    Psychol Med; 2017 Aug; 47(11):1923-1935. PubMed ID: 28249639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor outcome associated with symptomatic deterioration among help-seeking individuals at risk for psychosis: a naturalistic follow-up study.
    Morita K; Kobayashi H; Takeshi K; Tsujino N; Nemoto T; Mizuno M
    Early Interv Psychiatry; 2014 Feb; 8(1):24-31. PubMed ID: 23343086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.